{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2018,2,3]],"date-time":"2018-02-03T12:15:15Z","timestamp":1517660115575},"reference-count":4,"publisher":"Springer Nature","issue":"7","license":[{"URL":"http:\/\/www.springer.com\/tdm","start":{"date-parts":[[2002,7,1]],"date-time":"2002-07-01T00:00:00Z","timestamp":1025481600000},"delay-in-days":0,"content-version":"unspecified"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Nat Rev Drug Discov"],"published-print":{"date-parts":[[2002,7]]},"DOI":"10.1038\/nrd842","type":"journal-article","created":{"date-parts":[[2002,7,28]],"date-time":"2002-07-28T21:36:31Z","timestamp":1027892191000},"page":"491-492","source":"Crossref","is-referenced-by-count":37,"title":["Selective anticancer drugs"],"prefix":"10.1038","volume":"1","author":[{"given":"Joshua H.","family":"Atkins","affiliation":[]},{"given":"Leland J.","family":"Gershell","affiliation":[]}],"member":"339","published-online":{"date-parts":[[2002,7,1]]},"reference":[{"key":"BFnrd842_CR1","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1038\/nrd839","volume":"1","author":"R Capdeville","year":"2002","unstructured":"Capdeville, R. et al. Glivec (STI571, imatinib), a rationally developed targeted anticancer drug. Nature Rev. Drug Discov. 1, 493\u2013502 (2002).","journal-title":"Nature Rev. Drug Discov."},{"key":"BFnrd842_CR2","first-page":"2958","volume":"7","author":"F Ciardello","year":"2001","unstructured":"Ciardello, F. & Tortora, G. A novel approach in the treatment of cancer: targeting the epidermal growth factor receptor. Clin. Cancer Res. 7, 2958\u20132970 (2001).","journal-title":"Clin. Cancer Res."},{"key":"BFnrd842_CR3","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/S1535-6108(02)00039-9","volume":"1","author":"LK Shawver","year":"2002","unstructured":"Shawver, L. K., Slamon, D. & Ullrich, A. Smart drugs: tyrosine kinase inhibitors in cancer therapy. Cancer Cell 1, 117\u2013123 (2002).","journal-title":"Cancer Cell"},{"key":"BFnrd842_CR4","doi-asserted-by":"publisher","first-page":"23","DOI":"10.3322\/canjclin.52.1.23","volume":"52","author":"A Jem","year":"2002","unstructured":"Jem, A. et al. Cancer statistics, 2002. CA Cancer J. Clin. 52, 23\u201347 (2002)","journal-title":"CA Cancer J. Clin."}],"container-title":["Nature Reviews Drug Discovery"],"original-title":[],"link":[{"URL":"http:\/\/www.nature.com\/articles\/nrd842.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nrd842","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nrd842.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,2,1]],"date-time":"2018-02-01T04:39:28Z","timestamp":1517459968000},"score":1.0,"subtitle":[],"short-title":[],"issued":{"date-parts":[[2002,7]]},"references-count":4,"alternative-id":["BFnrd842"],"URL":"http:\/\/dx.doi.org\/10.1038\/nrd842","relation":{"cites":[]},"ISSN":["1474-1776","1474-1784"],"issn-type":[{"value":"1474-1776","type":"print"},{"value":"1474-1784","type":"electronic"}],"subject":["Pharmacology","Drug Discovery","General Medicine"]}}